RCS - Polar Cap Glb Health - Update from QuotedData

Polar Capital Global Healthcare TrustAnnouncement

13/11/2025 10:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251113:nRSM4319Ha&default-theme=true

RNS Number : 4319H  Polar Capital Global Health Tst PLC  13 November 2025

Polar Capital Global Healthcare - Update from QuotedData

13 November 2025

Decision time

Shareholders in Polar Capital Global Healthcare (PCGH) are being asked to
approve changes aimed at improving the trust's future prospects. These include
lower fees, a better structure, and regular five-yearly opportunities for all
investors to exit.

There is also an immediate exit option. Investors must decide whether to stay
invested. However, with PCGH trading close to its asset value, those wanting
to sell have already had the chance to do so in the market. We believe now is
not the time to leave the healthcare sector, which remains undervalued but
promising. In fact, we would consider increasing our investment.

Full Research:

https://quoteddata.com/research/polar-capital-global-healthcare-decision-time-qd/
(https://quoteddata.com/research/polar-capital-global-healthcare-decision-time-qd/)

This research is also available free on our website www.quoteddata.com
(http://www.quoteddata.com) where you will also find news, performance data
and factsheets on every London listed Investment Company. QuotedData writes
and distributes research on a number of quoted companies, facilitates meetings
between those companies and existing and potential investors and assists in
raising additional capital where required.

NB: Marten & Co was paid to produce this note Polar Capital Global
Healthcare Trust Plc, and it is for information purposes only. It is not
intended to encourage the reader to deal in the security or securities
mentioned in this report. Please read the important information at the back of
this note. QuotedData is a trading name of Marten & Co Limited which is
authorised and regulated by the Financial Conduct Authority. Marten & Co
is not permitted to provide investment advice to individual investors
categorised as Retail Clients under the rules of the Financial Conduct
Authority.

QUOTEDDATA

50 Gresham Street | London EC2V 7AY

Tel: +44 (0) 20 3691 9430

www.quoteddata.com (http://www.quoteddata.com) | research@quoteddata.com
(mailto:research@quoteddata.com) | www.martenandco.com
(http://www.martenandco.com)

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAPKNBKKBDDKDD



            Copyright 2019 Regulatory News Service, all rights reserved